TP53 and urinary bladder cancer: Mutations of p53 in the context of UGS-induced bladder cancers from Angola along with sialylated glycans have been suggested as surrogate biomarkers of bladder carcinogenesis associated with S. haematobium infection highlighting links between infection and cancer development52.